Sartorius Stedim Biotech (SSB) and SAFC Biosciences have signed a global partnership agreement. It combines Sartorius Stedim Biotech’s expertise in filtration and liquid handling systems, with SAFC Biosciences’
Wyeth Consumer Healthcare, a division of Wyeth, has reported the availability of a new, gender and age-specific adult multivitamin line. It is developed to help meet the nutritional
ImmunoVaccine (IVT) has entered into an agreement to exclusively license seven cancer antigens from Immunotope. The company said that these antigens will specifically target breast, ovarian and prostate
Bayer Schering Pharma has announced that its partner, Ortho-McNeil, does not expect to submit its complete response to FDA until the fourth quarter of this year. Kemal Malik,
Halozyme has initiated patient dosing in a Phase 2 clinical study of Insulin-PH20 in patients with type 2 diabetes mellitus. The company said that the phase 2 study
BioTech has contracted to start conducting independent clinical testing of its patented Shban Antiviral Hand Sanitizer Solution, to prove it kills the H1N1 (Swine) Influenza A virus in
Quantum Immunologics (QI) has announced that the first patient in its breast cancer trial has begun to receive its dendritic cell therapy. QI is currently sponsoring and conducting
We will continue to evaluate our operations and organization to ensure they are in line with our commitment to develop high quality systems, stated Dr. Gioacchino De Chirico,
The Perrigo has received approval from the FDA to market over-the-counter coated nicotine polacrilex lozenge USP, 2mg and 4mg in cherry and cinnamon flavors. The company said that
MacroGenics has initiated Paradigm trial, a phase 2 clinical study evaluating MGAWN1. MGAWN1 is a humanized monoclonal antibody, for the treatment of individuals with suspected central nervous system
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.